9.5
1K+ Ratings
American Society for Colposcopy and Cervical Pathology Inc
Developer
43.3 MB
Size
2024年10月11日
Update Date
#3
in Medical
17+
Age Rating
Age Rating
ASCCP Management Guidelines 螢幕截圖
About ASCCP Management Guidelines
New 2019 ASCCP Risk-Based Management Consensus Guidelines for abnormal cervical cancer screening tests and cancer precursors provide new recommendations.
ASCCP is pleased to offer this app to streamline navigation of the ASCCP Risk-Based Management Consensus Guidelines for abnormal cervical cancer screening tests and cancer precursors. The guidelines articles, as published in the Journal of Lower Genital Tract Disease, as well as the comprehensive risk estimates, can be accessed through https://www.asccp.org/guidelines.
These evidence-based management guidelines, initially developed in 2019, came together through a consensus process of 19 organizations. The updated management guidelines aim to:
• Allow for a more complete and precise estimation of risk
• Provide more appropriate intervention for high-risk individuals (detect and treat more precancer)
• Recommend less intervention for low-risk individuals (decrease testing and treatment that won’t prevent cancer and may cause reproductive harm)
• Allow for the future addition of new risk modifiers and screening and management technologies
See https://www.asccp.org/UserGuide for tips on using the app.
ASCCP is pleased to offer this app to streamline navigation of the ASCCP Risk-Based Management Consensus Guidelines for abnormal cervical cancer screening tests and cancer precursors. The guidelines articles, as published in the Journal of Lower Genital Tract Disease, as well as the comprehensive risk estimates, can be accessed through https://www.asccp.org/guidelines.
These evidence-based management guidelines, initially developed in 2019, came together through a consensus process of 19 organizations. The updated management guidelines aim to:
• Allow for a more complete and precise estimation of risk
• Provide more appropriate intervention for high-risk individuals (detect and treat more precancer)
• Recommend less intervention for low-risk individuals (decrease testing and treatment that won’t prevent cancer and may cause reproductive harm)
• Allow for the future addition of new risk modifiers and screening and management technologies
See https://www.asccp.org/UserGuide for tips on using the app.
Show More
最新版本2.0.1更新日誌
Last updated on 2024年10月11日
歷史版本
Dual Stain Management:
We’ve introduced enhanced support for managing Dual Stain results, providing a streamlined approach for more accurate analysis and decision-making.
SmartUI Enhancement:
Our updated SmartUI now intelligently guides you through patient history, enabling faster, more efficient recommendations based on key data points.
We’ve introduced enhanced support for managing Dual Stain results, providing a streamlined approach for more accurate analysis and decision-making.
SmartUI Enhancement:
Our updated SmartUI now intelligently guides you through patient history, enabling faster, more efficient recommendations based on key data points.
Show More
Version History
2.0.1
2024年10月11日
Dual Stain Management:
We’ve introduced enhanced support for managing Dual Stain results, providing a streamlined approach for more accurate analysis and decision-making.
SmartUI Enhancement:
Our updated SmartUI now intelligently guides you through patient history, enabling faster, more efficient recommendations based on key data points.
We’ve introduced enhanced support for managing Dual Stain results, providing a streamlined approach for more accurate analysis and decision-making.
SmartUI Enhancement:
Our updated SmartUI now intelligently guides you through patient history, enabling faster, more efficient recommendations based on key data points.
2.0
2024年10月10日
Dual Stain Management:
We’ve introduced enhanced support for managing Dual Stain results, providing a streamlined approach for more accurate analysis and decision-making.
SmartUI Enhancement:
Our updated SmartUI now intelligently guides you through patient history, enabling faster, more efficient recommendations based on key data points.
We’ve introduced enhanced support for managing Dual Stain results, providing a streamlined approach for more accurate analysis and decision-making.
SmartUI Enhancement:
Our updated SmartUI now intelligently guides you through patient history, enabling faster, more efficient recommendations based on key data points.
1.7
2022年02月24日
Recommendation updates based on new erratum publication.
1.6
2021年11月25日
Minor improvements to management recommendations and typographical errors
1.5
2021年09月24日
New Clinical Situations tree to aide in navigation.
Expanded app to include Screening Guidelines.
Expanded app to include Screening Guidelines.
1.3
2021年04月09日
New 2019 ASCCP Risk-Based Management Consensus Guidelines for abnormal cervical cancer screening tests and cancer precursors provide new recommendations.
1.2
2020年10月01日
New 2019 ASCCP Risk-Based Management Consensus Guidelines for abnormal cervical cancer screening tests and cancer precursors provide new recommendations.
1.1
2020年08月19日
New 2019 ASCCP Risk-Based Management Consensus Guidelines for abnormal cervical cancer screening tests and cancer precursors provide new recommendations.
1.0
2020年06月05日
ASCCP Management Guidelines 價格
今日:
HK$ 118.00
最低價格:
HK$ 78.00
最高價格:
HK$ 118.00
ASCCP Management Guidelines FAQ
點擊此處瞭解如何在受限國家或地區下載ASCCP Management Guidelines。
以下為ASCCP Management Guidelines的最低配置要求。
iPhone
須使用 iOS 11.2 或以上版本。
iPad
須使用 iPadOS 11.2 或以上版本。
iPod touch
須使用 iOS 11.2 或以上版本。
ASCCP Management Guidelines支持英文